Detection of SARS‐CoV‐2‐independent immunoregulatory activity of COVID‐19 convalescent plasma

BACKGROUND: Convalescent plasma has emerged as a potential specific treatment for coronavirus disease 2019 (COVID‐19), since it contains severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) antibodies. Several studies are currently investigating the efficacy of convalescent plasma for treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Brox, Regine, Achenbach, Susanne, Hackstein, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662056/
https://www.ncbi.nlm.nih.gov/pubmed/34546583
http://dx.doi.org/10.1111/trf.16685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662056/
https://www.ncbi.nlm.nih.gov/pubmed/34546583
http://dx.doi.org/10.1111/trf.16685

Ejemplares similares